Zhang, C., Liu, J., Gu, T., Meng, X., Cai, X., Zhang, J., . . . Wu, Y. (2025). Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin. Breast Cancer Research and Treatment, 211(3), 637-648. https://doi.org/10.1007/s10549-025-07676-9
Chicago-referens (17:e uppl.)Zhang, Chenxing, Jiaxin Liu, Tiejun Gu, Xiangyu Meng, Xiaoyi Cai, Jinfeng Zhang, Yan Chen, Daguang Zhang, och Yongge Wu. "Enhanced Antitumor Efficacy of Bispecific Antibody Blocking PD-L1 and LAG-3 with Doxorubicin." Breast Cancer Research and Treatment 211, no. 3 (2025): 637-648. https://doi.org/10.1007/s10549-025-07676-9.
MLA-referens (9:e uppl.)Zhang, Chenxing, et al. "Enhanced Antitumor Efficacy of Bispecific Antibody Blocking PD-L1 and LAG-3 with Doxorubicin." Breast Cancer Research and Treatment, vol. 211, no. 3, 2025, pp. 637-648, https://doi.org/10.1007/s10549-025-07676-9.
